[Utilization of economic evaluations of health interventions: the palivizumab case].
Puigventós Latorre
Francesc
F
Comas Gallardo
Francisca
F
Delgado Sánchez
Olga
O
Martínez López
Iziar
I
D000911:Antibodies, Monoclonal / Q000191:economics* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D005069:Evaluation Studies as Topic; D006302:Health Services Research; D000069455:Palivizumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069455:Palivizumab